Cargando…
Thrombin induced platelet-fibrin clot strength in relation to platelet volume indices and inflammatory markers in patients with coronary artery disease
Platelet aggregation and inflammation are both implicated in coronary artery disease (CAD). Thrombin induced platelet-fibrin clot strength (MA(Thrombin)) measured by thrombelastography (TEG) has been proved to be a novel marker of platelet aggregation. The aim of this study was to investigate the co...
Autores principales: | Lv, Hai-Chen, Wu, Hong-Yi, Yin, Jia-Sheng, Ge, Jun-Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609996/ https://www.ncbi.nlm.nih.gov/pubmed/28969064 http://dx.doi.org/10.18632/oncotarget.19450 |
Ejemplares similares
-
Hyperglycemia Is Associated With Enhanced Thrombin Formation, Platelet Activation, and Fibrin Clot Resistance to Lysis in Patients With Acute Coronary Syndrome
por: Undas, Anetta, et al.
Publicado: (2008) -
Integrating platelet and coagulation activation in fibrin clot formation
por: Swieringa, Frauke, et al.
Publicado: (2018) -
Relationship between ADP-induced platelet-fibrin clot strength and anti-platelet responsiveness in ticagrelor treated ACS patients
por: Li, Dan-Dan, et al.
Publicado: (2016) -
Platelet Counts in Insoluble Platelet-Rich Fibrin Clots: A Direct Method for Accurate Determination
por: Kitamura, Yutaka, et al.
Publicado: (2018) -
Thromboelastography (platelet contribution to clot strength) for the assessment of platelet residual function
por: Haxhiademi, D, et al.
Publicado: (2012)